diabetes type Articles
-
Type 1 Diabetes Treatment Market is anticipated to progress at a CAGR of 7.8% by 2032
The global Type 1 Diabetes Treatment market size was estimated to be US$ 7.02 Billion in 2022 and is geared to grow at a CAGR of 7.8% between 2023 to 2032.The Type 1 Diabetes Treatment market report is a combination of qualitative and quantitative data that highlights significant industry changes, obstacles that businesses and the competition must overcome, as well as new possibilities and trends ...
By insightSLICE
-
Project - Sublingual Exenatide
Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity. Until now, both ...
By BioLingus AG
-
Rapid Point-of-Care Test for Determination of C-Peptide Levels
Abstract C-peptide is co-secreted with insulin and is not subject to hepatic clearance and thus reflects functional β-cell mass. Assessment of C-peptide levels can identify individuals at risk for or with type 1 diabetes with residual β-cell function in whom β cell-sparing interventions can be evaluated, and can aid in distinguishing type 2 diabetes from Latent Autoimmune Diabetes ...
-
Diabetes faces iPeak technology
DiabetOmics DiabetOmics®, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and diabetes. They operate in USA and India. The primary area of focus is the diabetes market with products related to the detection ...
By IUL S.A.
-
Management of Type 2 Diabetesusing non-invasive CGM
There is compelling evidence suggesting Type 2 diabetes may be managed by use of a Continuous Gucose Monitor (CGM) on non consecutive days, leading to clinically significant outcomes. Invasive CGMs are generally designed for wear periods of up to 14 consecutive days: with the associated cost. The additional costs are not justified where significant clinical outcomes can potentially be achieved ...
-
Project - Sublingual Dual Incretin Inhibitor (GLP-1/GIP)
Biolingus explores the development of a sublingual dual incretin inhibitor. BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : More than 400 MM people suffer from diabetes today. The global type 2 diabetes market is expected to grow to $58.7 billion by 2025, with an annual growth rate of 6.5%, according to research and consulting ...
By BioLingus AG
-
Project - Sublingual IL2 (BL SLIT I)
The aim of this project is to develop low dose IL-2 for treatment of early onset juvenile Type I diabetes. Low dose injectable IL-2 in animal models has been shown to restore the balance between regulatory and effector T cells and, in this way, can help to reverse autoimmunity and the development of type I diabetes. Looking ahead, we anticipate that having a suitable oral formulation of IL-2 to ...
By BioLingus AG
-
Effects of tobacco (smoking and snuffing) in type 2 diabetic patients
The present study aimed to evaluate the effects of tobacco on different biochemical and physical parameters in type 2 diabetic subjects from Dera Ismail Khan, NWFP, Pakistan. A total of 100 chronic type 2 diabetic patients of different age and sex with no tobacco addiction and with tobacco addiction were requested to volunteer their complete biodata on a given Performa. Blood biochemical ...
-
Overview of Diabetes: Prevalence Assessment, Treatment And Prevention
Diabetes is a chronic disease that affects more than 540 million people worldwide and is one of the leading causes of death and disability worldwide. In China, there are more than 114 million adults with diabetes, accounting for about a quarter of the world's diabetes patients. With the change of living and eating habits, diabetes has become the third major factor affecting human health after ...
-
Is deodorant causing this man’s underarm rash? Let’s diagnose
A 53-year-old man visited his doctor concerned about a spreading rash underneath his arms for the past 3 weeks. He initially thought it was an allergic reaction to a new deodorant, but it wasn’t itchy, and it persisted after stopping the deodorant. The patient had a history of type 2 diabetes. On examination, a broad, well-demarcated, thin, scaly plaque was seen extending from the ...
By VisualDx
-
The Reality of Diabetes Reversal
The conversation around diabetes reversal has increased, and when researching diabetes there are numerous states to this claim, but how realistic is it? Sadly, diabetes affects a huge number of people worldwide and is responsible for blindness, kidney disease, limb amputation and death. WHO estimates that diabetes was the seventh leading cause of death in 2016[1] and 422 million adults currently ...
-
Suppressive effect of low-dose X-irradiation on type I diabetes non-obese diabetic (NOD) mice
We examined the effect of X-irradiation (0, 0.25, 0.5 or 1.0 Gy) on the onset of the type I diabetes (insulin dependent diabetes mellitus) in non-obese diabetic (NOD) mice. NOD mice are characterised by a progressive loss of insulin-producing β-cells in the pancreas by autoimmune mechanisms. The destruction of β-cells is known to be due to apoptosis induced by oxidative stress caused by ROS. In ...
-
A Closer Look at Metabolic Disease Models and Diabetes Models
Diabetes, specifically Type 1 and Type 2 Diabetes Mellitus, remains one of the most commonly encountered metabolic diseases worldwide. The complexity and diversity of these conditions necessitate the development of detailed medical models for a comprehensive understanding of the diseases. Over time, Type 1 and Type 2 Diabetes Mellitus Models, Metabolic Disease Models, and generalized Diabetes ...
-
UK Imaging Diabetes Study Seeing Diabetes Clearly - Case Study
Prospective observational cohort study with clinical outcomes data collection. Recruiting adult patients with type 2 diabetes (T2DM) and diabetic retinopathy (DR), who lack history of cardiovascular ...
By Perspectum
-
Project - Turnkey water system for Aesica Pharmaceuticals
In 2013 Aesica, supplier of Active Pharmaceutical Ingredients (API) and finished dose manufacturing to the pharmaceutical industry, unveiled its new high capacity manufacturing facility specifically built to produce a solid dose medication for treating Type 2 diabetes in adults. Puretech supplied the turnkey water system for the facility, including pre-treatment, 3mr/hr Oasys, 10,000 litre ...
-
Project - Sublingual insulin+ (fixed dose combination product of insulin and exenatide/liraglutide)
The global human insulin market is projected to surpass USD 40 Billion USD. Our sublingual “insulin+” product will be positioned in a particular segment of this market : it will be prescribed for type II diabetes patients, who do not respond sufficiently to GLP-1 analogues alone. Such a fixed dose combination is already on the market under the brand name Xultophy, which is a ...
By BioLingus AG
-
Diabetes: Medications, Treatments, and Remedies
Lifestyle can have a big impact on how your body handles blood glucose and sometimes a change in habits and activities is all that’s needed to prevent or better manage diabetes. But if changes in lifestyle aren’t enough to keep blood sugar levels normal, your doctor may prescribe medication to help lower insulin levels or insulin therapy. We’ll discuss here the most often ...
By Genteel LLC
-
Diabetic Foot Ulcer - Case study
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. The surgeon took the patient to the OR for debridement, drained the infection, and started antibiotics. The patient was treated with advanced modalities that included NPWT and a bioengineered skin substitute. Primary Diagnosis ...
-
A Break Through in Diabetes Testing and Monitoring: Exclusive Interview with Asad Zaidi CEO of Epinex Diagnostics, Inc.
Not a day goes by without any news on diabetes. It is one the world’s most debilitating chronic disease. The number of people with diabetes is estimated to be over 500 Million, and it is increasing at an alarming rate of 9% every year. Diabetes is also rising more rapidly in the middle and low-income countries. It is one of the leading causes of death in the world. More than 100 million ...
-
How to support healthy blood sugar levels.
Healthy blood sugar levels are important for everyone. Maintaining healthy blood sugar levels can help reduce the risk of developing diabetes, kidney dysfunction, and problems with your eyes, gums, and nerves. Day-to-day healthy blood sugar levels will help with balancing energy levels, maintaining focus, and stabilizing mood. What Is “Blood Sugar?” Blood sugar, also known as ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you